The UMB Digital Archive is getting an upgrade! The upgrade requires a content freeze starting 1/27/25 and is expected to last two weeks. Any new user accounts or submissions made to the Archive during this time will not be transferred to the upgraded site. Contact ArchiveHelp@hshsl.umaryland.edu for questions.
Integrated Drug Reviews at the US Food and Drug Administration-Legal Concerns and Knowledge Lost.
| dc.contributor.author | Herder, Matthew | |
| dc.contributor.author | Morton, Christopher J. | en_US |
| dc.contributor.author | Doshi, Peter | en_US |
| dc.date.accessioned | 2020-03-16T14:27:53Z | |
| dc.date.available | 2020-03-16T14:27:53Z | |
| dc.date.issued | 2020-03-02 | |
| dc.identifier.uri | http://hdl.handle.net/10713/12226 | |
| dc.description | Viewpoint article discussing the FDA’s June 2019 announcement regarding its intention to replace individual scientific reviews with integrated drug reviews for new drugs. The authors express concerns over the loss of critical data as well as the legal ramifications associated with a 2007 Congressional law and the FDA’s own Equal Voice Initiative instituted in 2008. | en_US |
| dc.description.uri | https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2762578 | en_US |
| dc.language.iso | en_US | en_US |
| dc.publisher | American Medical Association | en_US |
| dc.relation.ispartof | JAMA Internal Medicine | en_US |
| dc.subject | FDA | en_US |
| dc.subject | individual scientific reviews | en_US |
| dc.subject | integrated drug reviews | en_US |
| dc.subject.lcsh | United States. Food and Drug Administration | en_US |
| dc.title | Integrated Drug Reviews at the US Food and Drug Administration-Legal Concerns and Knowledge Lost. | en_US |
| dc.type | Article | en_US |
| dc.identifier.doi | 10.1001/jamainternmed.2020.0074 | |
| dc.identifier.pmid | 32119058 | |
| dc.identifier.ispublished | Yes | en_US |
| dc.source.journaltitle | JAMA internal medicine |
